farnesol and Leukemia, Promyelocytic, Acute

farnesol has been researched along with Leukemia, Promyelocytic, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katagiri, T; Kizaki, M; Miyazawa, K; Nishimaki, J; Tohyama, K; Toyama, K; Yaguchi, M1
Doe, M; Hamada, M; Nishio, K; Tanaka, T; Usuki, Y1

Other Studies

2 other study(ies) available for farnesol and Leukemia, Promyelocytic, Acute

ArticleYear
Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid.
    Leukemia, 1997, Volume: 11, Issue:6

    Topics: Apoptosis; Bone Marrow; Diterpenes; Drug Synergism; Farnesol; Flow Cytometry; Gefarnate; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Molecular Structure; Myelodysplastic Syndromes; Structure-Activity Relationship; Tretinoin; Tumor Cells, Cultured; Vitamin K; Vitamin K 1; Vitamin K 2

1997
Farnesylpyridinium, an analog of isoprenoid farnesol, induces apoptosis but suppresses apoptotic body formation in human promyelocytic leukemia cells.
    FEBS letters, 2002, Mar-13, Volume: 514, Issue:2-3

    Topics: Actin Cytoskeleton; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Cysteine Proteinase Inhibitors; Cytochalasin B; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Farnesol; HL-60 Cells; Humans; Inclusion Bodies; Leukemia, Promyelocytic, Acute; Mitochondria; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Pyridinium Compounds; Sesquiterpenes

2002